CBD GW Pharmaceuticals’ Cannabis-Based Epilepsy Drug Gets EU Approval U.S. Epidiolex sales have surged on strong patient uptake and now the CBD-based epilepsy drug could be sold in 31 European countries after EU... Jared GnamSeptember 24, 2019